医学
转移瘤切除术
结直肠癌
肿瘤科
化疗
内科学
背景(考古学)
卵巢癌
全身疗法
转移
细胞减少术
疾病
卵巢
揭穿
回顾性队列研究
癌症
原发性肿瘤
外科切除术
外科
阶段(地层学)
局限性疾病
直肠
上皮性卵巢癌
切除术
总体生存率
作者
James B. E. Weil,Annekathryn Goodman
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2026-09-24
卷期号:12 (11): 1281-1281
标识
DOI:10.1001/jamaoncol.2026.3634
摘要
Importance: Colorectal cancer is the third most common and deadly cancer among women worldwide. Although ovarian metastases from colon cancer are relatively uncommon, they remain clinically significant due to their association with poor prognosis and the longstanding suspicion that the ovaries may function as a chemotherapy-resistant sanctuary site. This review examines the evidence for this phenomenon and potential role of surgical resection of metastatic disease. Observations: Twenty-four retrospective studies comprising 2705 patients with ovarian metastases from colorectal cancer were evaluated. Ovarian metastases demonstrated lower objective chemotherapy response rates than extraovarian metastases, had substantially lower mean shrinkage, and frequently exhibited discordant growth during treatment. The most favorable outcomes associated with improved survival were observed in patients who had complete surgical resection of ovarian metastases and microscopically negative margins. Conclusions: Collectively, the literature supports the ovary functioning as a relative sanctuary site in metastatic colorectal cancer, suggesting that systemic therapy alone should not be regarded as adequate. Instead, systemic therapy assumes a complementary role in reducing overall tumor burden and improving candidacy for resection. Therefore, optimal management should aim for clearance of all macroscopic disease, with negative surgical margins pursued when feasible. Metastasectomy should be performed within the context of comprehensive disease control, including resection of the primary tumor.
科研通智能强力驱动
Strongly Powered by AbleSci AI